3Tsutsumi H, Katagi M, Miki A, et al. Development of simuhaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine ( BZP ), 1-( 3- trifluoromethylphenyl) piperazine ( TFMPP ) and their main metabolites in urine [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci. 2005,819(2) :315-322.
4Baumann M H, Clark R D, Budzynski A G, et al. N- substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methlenedioxymethamphetamine ( MDMA, or ' Ecstasy' ) [ J ]. Neuropsychopharmacology, 2005,30 ( 3 ) : 550-560.
二级参考文献4
1Kerr J R, Davis L S. Benzylpiperazine in New Zealand: brief history and current implications[J].Journal of the Royal Society of New Zealand. 2011, 41(1): 155-164.
2H. Tsutsumi M, Katagi A, NKId N, et al. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography- dectmspmy ionisation mass spectrometric determination method for the new designer drugs, N- benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and their main rnetabolites in urine[J]. Journal of Chromatography R 2005, 819: 315-322.
3Baumann M H, Clark R D, Budzynski A G, et al. N- substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')[J]. Neuropsychopharmacology. 2005, 30(3): 550-560.
